Hemodynamics, fluids & transfusion

Severe bleeding events among critically ill patients with haematological malignancies

Ann Intensive CarePublished Retrospective cohort study

Authors' conclusion

Major bleeding events are common complications in critically ill patients with haematological malignancies and are associated with a worsened prognosis.

Study context

Population
Adults with a history of haematological malignancy requiring unplanned ICU admission, 2007–2018analysed
Participants
1,012 adults
Exposure
Bleeding vs Non-bleeding
  • Bleedingn = 109
Outcome
ICU-acquired (after the first 24 h in the ICU) severe bleeding events (WHO grades 3 or 4)
Methodological detailssingle-center
  • Single-center

Main finding

As reported in the abstract

ICU-acquired severe bleeding events (WHO grade 3 or 4)

Patients with ICU-acquired severe bleeding events

109

10.8%

Time in ICU to bleeding event

3.0 days

1.0–7.0

Main source of bleeding: gastrointestinal tract

n = 44, 40.3%

Observational data: associations, not effects.

Further findings

In-ICU mortality

P < 0.001

In-hospital mortality

P < 0.001

Independent predictors of ICU-acquired severe bleeding (multivariate) · day prior to the event

CSH (CI)P value
Primary bleeding event at ICU admission4.17 (2.71–6.43)P < 0.001
Non-platelet SOFA scorePer point increase1.06 (1.01–1.11)P = 0.02
Prolonged prothrombin timePer 5-percent increase0.90 (0.85–0.96)P = 0.001
OutcomeBleedingNon-bleedingCause-specific hazard (CI)P value
ICU LOS9.0 (range 1.0–6.0) days3.0 (range 3.5–15.0)P < 0.001
Independent predictors of ICU-acquired severe bleeding (multivariate) · day prior to the eventCKD2.00 (1.19–3.31)P = 0.008
Main source of bleeding: gastrointestinal tract
40.3% · 44 of 109

Original publication

Severe bleeding events among critically ill patients with haematological malignancies. Ann Intensive Care. Published 7 October 2024. doi:10.1186/s13613-024-01383-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.